HEPION PHARMACEUTICALS, INC. Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount
HEPION PHARMACEUTICALS, INC. (HEPA) reported Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount of 3.48 million shares for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Income Statement › Earnings Per Share
us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount · last filed 2026-08-13
- HEPION PHARMACEUTICALS, INC. antidilutive securities excluded from computation of earnings per share, amount for the quarter ending 2026-03-31 was 3.48M shares, a 0.59% decline year-over-year.
- HEPION PHARMACEUTICALS, INC. antidilutive securities excluded from computation of earnings per share, amount for the quarter ending 2025-03-31 was 3.50M shares, a 5149.83% increase year-over-year.
- HEPION PHARMACEUTICALS, INC. antidilutive securities excluded from computation of earnings per share, amount for the quarter ending 2024-03-31 was 66.71K shares, a 89.91% decline year-over-year.
- HEPION PHARMACEUTICALS, INC. antidilutive securities excluded from computation of earnings per share, amount for the quarter ending 2023-09-30 was 637.00K shares, a 3.67% decline year-over-year.
- HEPION PHARMACEUTICALS, INC. antidilutive securities excluded from computation of earnings per share, amount for fiscal 2025 was 3.48M shares, a 5742.24% increase from fiscal 2024.
- HEPION PHARMACEUTICALS, INC. antidilutive securities excluded from computation of earnings per share, amount for fiscal 2024 was 59.65K shares, a 16.29% increase from fiscal 2023.
- HEPION PHARMACEUTICALS, INC. antidilutive securities excluded from computation of earnings per share, amount for fiscal 2023 was 51.29K shares, a 92.24% decline from fiscal 2022.
- HEPION PHARMACEUTICALS, INC. antidilutive securities excluded from computation of earnings per share, amount for fiscal 2022 was 661.30K shares, a 94.96% decline from fiscal 2021.
| Period end | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 3 month | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 3 month as first filed | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 6 month | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 6 month as first filed | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 9 month | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 9 month as first filed | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 12 month | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | 3.48M shares 10-Q · filed 2026-08-13 | |||||||
| 2026-03-31 | 3.48M shares 10-Q · filed 2026-05-14 | |||||||
| 2025-12-31 | 3.48M shares 10-K · filed 2026-03-12 | |||||||
| 2025-09-30 | 3.49M shares 10-Q · filed 2025-11-12 | |||||||
| 2025-06-30 | 3.50M shares 10-Q · filed 2026-08-13 | |||||||
| 2025-03-31 | 3.50M shares 10-Q · filed 2026-05-14 | |||||||
| 2024-12-31 | 59.65K shares 10-K · filed 2026-03-12 | |||||||
| 2024-09-30 | 61.21K shares 10-Q · filed 2025-11-12 | 3.06M shares 10-Q · filed 2024-11-14 | ||||||
| 2024-06-30 | 62.98K shares 10-Q · filed 2025-08-14 | 3.15M shares 10-Q · filed 2024-08-13 | ||||||
| 2024-03-31 | 66.71K shares 10-Q · filed 2025-05-19 | 3.34M shares 10-Q · filed 2024-05-21 | ||||||
| 2023-12-31 | 51.29K shares 10-K · filed 2025-04-08 | 2.56M shares 10-K · filed 2024-04-16 | ||||||
| 2023-09-30 | 637.00K shares 10-Q · filed 2023-11-20 | 637.00K shares 10-Q · filed 2024-11-14 | ||||||
| 2023-06-30 | 661.09K shares 10-Q · filed 2024-08-13 | |||||||
| 2023-03-31 | 661.18K shares 10-Q · filed 2024-05-21 | |||||||
| 2022-12-31 | 661.30K shares 10-K · filed 2024-04-16 | 13.23M shares 10-K · filed 2023-04-10 | ||||||
| 2022-09-30 | 661.30K shares 10-Q · filed 2023-11-20 | 661.30K shares 10-Q · filed 2023-11-20 | 13.23M shares 10-Q · filed 2022-11-14 | |||||
| 2022-06-30 | 661.30K shares 10-Q · filed 2023-08-14 | 13.23M shares 10-Q · filed 2022-08-15 | ||||||
| 2022-03-31 | 655.83K shares 10-Q · filed 2023-05-12 | 13.12M shares 10-Q · filed 2022-05-16 | ||||||
| 2021-12-31 | 13.12M shares 10-K · filed 2023-04-10 | |||||||
| 2021-09-30 | 13.12M shares 10-Q · filed 2022-11-14 | 13.12M shares 10-Q · filed 2021-11-15 | ||||||
| 2021-06-30 | 13.12M shares 10-Q · filed 2022-08-15 | |||||||
| 2021-03-31 | 6.81M shares 10-Q · filed 2022-05-16 | |||||||
| 2020-12-31 | 5.70M shares 10-K · filed 2022-04-08 | |||||||
| 2020-09-30 | 5.02M shares 10-Q · filed 2021-11-15 | |||||||
| 2020-06-30 | 3.96M shares 10-Q · filed 2021-08-16 | |||||||
| 2020-03-31 | 2.60M shares 10-Q · filed 2021-05-14 | |||||||
| 2019-12-31 | 2.67M shares 10-K · filed 2021-03-31 | |||||||
| 2019-09-30 | 2.87M shares 10-Q · filed 2020-11-16 | 2.89M shares 10-Q · filed 2019-11-14 | ||||||
| 2019-06-30 | 2.87M shares 10-Q · filed 2020-08-12 | |||||||
| 2019-03-31 | 141.96K shares 10-Q · filed 2020-06-29 | 9.94M shares 10-Q · filed 2019-05-15 | ||||||
| 2018-12-31 | 142.55K shares 10-K · filed 2020-05-14 | 9.98M shares 10-K · filed 2019-03-14 | ||||||
| 2018-09-30 | 143.80K shares 10-Q · filed 2019-11-14 | 10.06M shares 10-Q · filed 2018-11-14 | ||||||
| 2018-06-30 | 35.74K shares 10-Q · filed 2019-08-14 | 3.04M shares 10-Q · filed 2018-08-14 | ||||||
| 2018-03-31 | 2.55M shares 10-Q · filed 2019-05-15 | 20.40M shares 10-Q · filed 2018-05-15 | ||||||
| 2017-12-31 | 2.55M shares 10-K · filed 2019-03-14 | 20.40M shares 10-KT · filed 2018-03-26 | ||||||
| 2017-09-30 | 20.25M shares 10-Q · filed 2017-11-14 | 2.53M shares 10-Q · filed 2018-11-14 | ||||||
| 2017-06-30 | 2.54M shares 10-Q · filed 2018-08-14 | 1.76M shares 10-K · filed 2019-03-14 | 14.33M shares 10-K · filed 2017-09-28 | |||||
| 2017-03-31 | 13.96M shares 10-Q · filed 2018-05-15 | 11.90M shares 10-Q · filed 2017-04-12 | ||||||
| 2016-12-31 | 13.75M shares 10-Q · filed 2017-02-14 | |||||||
| 2016-09-30 | 15.02M shares 10-Q · filed 2017-11-14 | |||||||
| 2016-06-30 | 37.78M shares 10-KT · filed 2018-03-26 | |||||||
| 2016-03-31 | 34.17M shares 10-Q · filed 2017-04-12 | |||||||
| 2015-12-31 | 34.13M shares 10-Q · filed 2017-02-14 | |||||||
| 2015-09-30 | 31.22M shares 10-Q · filed 2016-11-14 | |||||||
| 2015-06-30 | 31.23M shares 10-K · filed 2016-09-28 | |||||||
| 2015-03-31 | 30.95M shares 10-Q · filed 2015-05-14 | 30.95M shares 10-Q · filed 2015-05-14 | ||||||
| 2014-12-31 | 24.49M shares 10-Q · filed 2015-02-12 | 24.49M shares 10-Q · filed 2015-02-12 | ||||||
| 2014-09-30 | 2.30M shares 10-Q · filed 2014-11-13 | |||||||
| 2014-06-30 | 7.08M shares 10-K · filed 2015-09-25 | |||||||
| 2014-03-31 | 2.14M shares 10-Q · filed 2015-05-14 | 2.14M shares 10-Q · filed 2015-05-14 | ||||||
| 2013-12-31 | 204.00K shares 10-Q · filed 2015-02-12 | 204.00K shares 10-Q · filed 2015-02-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Transcode Therapeutics, Inc. (RNAZ) | United States | $0.029B | -0.12 |
| KYNTRA BIO, INC. (KYNB) | United States | $0.028B | 0.17 |
| IGC Pharma, Inc. (IGC) | United States | $0.029B | -5.98 |
| BeyondSpring Inc. (BYSI) | United States | $0.031B | -10.95 |
| NANOVIRICIDES, INC. (NNVC) | United States | $0.031B | |
| CHINA PHARMA HOLDINGS, INC. (CPHI) | $0.032B | ||
| AYTU BIOPHARMA, INC (AYTU) | United States | $0.025B | -1.62 |
| Propanc Biopharma, Inc. (PPCB) | $0.032B | -0.13 | |
| NextCure, Inc. (NXTC) | United States | $0.024B | -0.15 |
| TherapeuticsMD, Inc. (TXMD) | United States | $0.024B | -117.87 |